BDRX - Why Biodexa Pharmaceuticals (BDRX) Shares Are Getting Hammered | Benzinga
Biodexa Pharmaceuticals PLC-ADR (NASDAQ: BDRX) shares are trading lower by 31.7% to $2.07 Tuesday morning after the company disclosed the pricing of a public offering. The offering includes two types of units:
- Class A Units: 697,614 units offered at $2.00 each, consisting of one Depositary Share (representing 400 ...
BDRX) Shares Are Getting Hammered>Full story available on Benzinga.com